Literature DB >> 26081290

The human immunodeficiency virus-reverse transcriptase inhibition activity of novel pyridine/pyridinium-type fullerene derivatives.

Takumi Yasuno1, Tomoyuki Ohe2, Kyoko Takahashi1, Shigeo Nakamura3, Tadahiko Mashino4.   

Abstract

In the present study, we describe the synthesis of a novel set of pyridine/pyridinium-type fullerene derivatives. The products were assessed for human immunodeficiency virus-reverse transcriptase inhibition activities. All novel fullerene derivatives showed potent human immunodeficiency virus-reverse transcriptase inhibition without cytotoxicity.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Fullerene; HIV reverse transcriptase; Human immunodeficiency virus (HIV)

Mesh：

Substances：

Year:  2015        PMID： 26081290     DOI： 10.1016/j.bmcl.2015.05.086

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN： 0960-894X            Impact factor:   2.823


  8 in total

1.  Fullerenes in Biology and Medicine.

Authors:  Edison Castro; Andrea Hernandez Garcia; Gerardo Zavala; Luis Echegoyen
Journal:  J Mater Chem B       Date:  2017-07-08       Impact factor: 6.331

2.  Potential Suppressive Effects of Two C60 Fullerene Derivatives on Acquired Immunity.

Authors:  Toshiro Hirai; Yasuo Yoshioka; Asako Udaka; Eiichiro Uemura; Tomoyuki Ohe; Hisae Aoshima; Jian-Qing Gao; Ken Kokubo; Takumi Oshima; Kazuya Nagano; Kazuma Higashisaka; Tadahiko Mashino; Yasuo Tsutsumi
Journal:  Nanoscale Res Lett       Date:  2016-10-06       Impact factor: 4.703

3.  Advances in Antiviral Material Development.

Authors:  Lili Liang; Ashiq Ahamed; Liya Ge; Xiaoxu Fu; Grzegorz Lisak
Journal:  Chempluschem       Date:  2020-08-21       Impact factor: 3.210

4.  A pyridinium‑type fullerene derivative suppresses primary effusion lymphoma cell viability via the downregulation of the Wnt signaling pathway through the destabilization of β‑catenin.

Authors:  Ayano Kadota; Misato Moriguchi; Tadashi Watanabe; Yuichi Sekine; Shigeo Nakamura; Takumi Yasuno; Tomoyuki Ohe; Tadahiko Mashino; Masahiro Fujimuro
Journal:  Oncol Rep       Date:  2022-01-11       Impact factor: 3.906

5.  Fullerene Derivatives Prevent Packaging of Viral Genomic RNA into HIV-1 Particles by Binding Nucleocapsid Protein.

Authors:  Ivana Křížová; Alžběta Dostálková; Edison Castro; Jan Prchal; Romana Hadravová; Filip Kaufman; Richard Hrabal; Tomáš Ruml; Manuel Llano; Luis Echegoyen; Michaela Rumlová
Journal:  Viruses       Date:  2021-12-06       Impact factor: 5.048

Review 6.  Progress in Antiviral Fullerene Research.

Authors:  Piao-Yang Xu; Xiao-Qing Li; Wei-Guang Chen; Lin-Long Deng; Yuan-Zhi Tan; Qianyan Zhang; Su-Yuan Xie; Lan-Sun Zheng
Journal:  Nanomaterials (Basel)       Date:  2022-07-24       Impact factor: 5.719

7.  Fullerene Derivatives of Nucleoside HIV Reverse Transcriptase Inhibitors-In Silico Activity Prediction.

Authors:  Aleksandra Dąbrowska; Tomasz Pieńko; Przemysław Taciak; Katarzyna Wiktorska; Zdzisław Chilmonczyk; Aleksander P Mazurek; Adam Stasiulewicz
Journal:  Int J Mol Sci       Date:  2018-10-19       Impact factor: 5.923

8.  Synthesis and antitumor activity of novel pyridinium fullerene derivatives.

Authors:  Takumi Yasuno; Tomoyuki Ohe; Hitomi Ikeda; Kyoko Takahashi; Shigeo Nakamura; Tadahiko Mashino
Journal:  Int J Nanomedicine       Date:  2019-08-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.